Literature DB >> 22552690

Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles.

D Stoop1, B Ermini, N P Polyzos, P Haentjens, M De Vos, G Verheyen, P Devroey.   

Abstract

BACKGROUND Live birth per cycle and live birth per embryo transfer are commonly used outcome measures for IVF treatment. In contrast, the assessment of the reproductive efficiency of human oocytes fertilized in vitro is seldom performed on an egg-to-egg basis. This approach may however gain importance owing to the increasingly widespread use of oocyte cryopreservation, as the technique is becoming more established. The aim of the current study is to quantify the reproductive efficiency of the oocyte according to ovarian ageing and ovarian response. METHODS We performed a retrospective analysis of the outcome of all consecutive patients attending for treatment between 1992 and 2009. The outcome in terms of live birth after fresh and cryopreserved embryo transfer per mature oocyte was calculated for 207 267 oocytes retrieved in 23 354 ovarian stimulation cycles. The oocyte utilization rate (number of live births per mature oocyte) was further analysed in relation to the ovarian response. RESULTS The oocyte utilization rate in women in the age of ≤ 37 years remains constant with a mean of 4.47% live birth per mature oocyte [95% confidence interval (CI): 4.32-4.61]. From the age of 38 years onwards, a significantly lower oocyte utilization rate was noted, declining from 3.80% at the age of 38 years to 0.78% at 43 years (P < 0.001). In this 38-43 years age group, oocyte utilization rate was no longer dependent on ovarian response (P = 0.87). CONCLUSIONS The major strength of the study, which is also its weakness, is the fact that we included a large number of cycles performed over a long period of time. According to our results, the oocyte utilization rate between 23 and 37 years of age depends largely on ovarian response and to a much lesser extent on age. From the age of 38 years onwards, the utilization rate depends largely on age and to a much lesser extent on ovarian response. Considering the increased use of oocyte freezing for fertility preservation, these data are extremely valuable as they provide an estimate of the number of oocytes needed to achieve a live birth.

Entities:  

Mesh:

Year:  2012        PMID: 22552690     DOI: 10.1093/humrep/des131

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

1.  Cumulus-corona gene expression analysis combined with morphological embryo scoring in single embryo transfer cycles increases live birth after fresh transfer and decreases time to pregnancy.

Authors:  T Adriaenssens; I Van Vaerenbergh; W Coucke; I Segers; G Verheyen; E Anckaert; M De Vos; J Smitz
Journal:  J Assist Reprod Genet       Date:  2019-01-09       Impact factor: 3.412

2.  Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.

Authors:  Philippe Merviel; Michel Menard; Rosalie Cabry; Florence Scheffler; Emmanuelle Lourdel; Marie-Thérèse Le Martelot; Sylvie Roche; Jean-Jacques Chabaud; Henri Copin; Hortense Drapier; Moncef Benkhalifa; Damien Beauvillard
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

Review 3.  Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events.

Authors:  Marco Conti; Federica Franciosi
Journal:  Hum Reprod Update       Date:  2018-05-01       Impact factor: 15.610

4.  Effects of laser-assisted thinning versus opening on clinical outcomes according to maternal age in patients with repeated implantation failure.

Authors:  Jung-Woo Lee; Jeong-Ho Cha; Sun-Hee Shin; Yun-Jeong Kim; Seul-Ki Lee; Choon-Keun Park; Kyung-Ah Pak; Ji-Sung Yoon; Seo-Young Park
Journal:  Lasers Med Sci       Date:  2019-05-01       Impact factor: 3.161

5.  Maternal physical activity and sedentary behaviour before and during in vitro fertilization treatment: a longitudinal study exploring the associations with controlled ovarian stimulation and pregnancy outcomes.

Authors:  Deniss Sõritsa; Evelin Mäestu; Margit Nuut; Jarek Mäestu; Jairo H Migueles; Siret Läänelaid; Aivar Ehrenberg; Aire Sekavin; Andrei Sõritsa; Andres Salumets; Francisco B Ortega; Signe Altmäe
Journal:  J Assist Reprod Genet       Date:  2020-06-23       Impact factor: 3.412

6.  Multiplexed detection and the establishment of a novel high-throughput method for human germ cell quality screening based on aggregation-induced emission.

Authors:  Zixuan Zeng; Xiaojiao Ren; Tailang Yin; Xiang Gao; Mengting Tsai; Yi Zhang; Meijia Gu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

7.  Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?

Authors:  Sara Cesarano; Paul Pirtea; Achraf Benammar; Dominique De Ziegler; Marine Poulain; Alberto Revelli; Chiara Benedetto; Alexandre Vallée; Jean Marc Ayoubi
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

8.  The total pregnancy potential per oocyte aspiration after assisted reproduction-in how many cycles are biologically competent oocytes available?

Authors:  J G Lemmen; N M Rodríguez; L D Andreasen; A Loft; S Ziebe
Journal:  J Assist Reprod Genet       Date:  2016-04-06       Impact factor: 3.357

9.  Developmental potential of immature human oocytes aspirated after controlled ovarian stimulation.

Authors:  Rachel S Mandelbaum; Michael S Awadalla; Meghan B Smith; Caroline J Violette; Brittany L Klooster; Rachel B Danis; Lynda K McGinnis; Jacqueline R Ho; Kristin A Bendikson; Richard J Paulson; Ali Ahmady
Journal:  J Assist Reprod Genet       Date:  2021-06-24       Impact factor: 3.357

Review 10.  Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation.

Authors:  P E Levi Setti; C Alviggi; G L Colombo; C Pisanelli; C Ripellino; S Longobardi; P L Canonico; G De Placido
Journal:  J Endocrinol Invest       Date:  2014-12-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.